Related Experiment Video
Updated: Oct 7, 2025

Murine Kidney Transplant Technique
Published on: October 20, 2015
Coronavirus disease 2019 infection in kidney transplant recipients: A clinical case series
Masoumeh Asgharpour1, Zeinab Mohseni Afshar2, Soheil Ebrahimpour3
1Department of Nephrology, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Insights
Kidney transplant recipients face higher risks for severe COVID-19. Immunosuppressive therapy may mitigate severe outcomes by preventing cytokine storms, though high D-dimer levels indicate a worse prognosis.
Area of Science:
- Nephrology
- Infectious Diseases
- Immunology
Background:
- Kidney transplant recipients (KTRs) are vulnerable to severe coronavirus disease 2019 (COVID-19) due to comorbidities and chronic immunosuppression.
- Understanding COVID-19 outcomes in KTRs is crucial for managing this high-risk population.
Observation:
- This study presents four cases of COVID-19 infection in kidney transplant recipients.
- Clinical data, including D-dimer levels and immunosuppressive regimens, were analyzed for each case.
Findings:
- One patient with high D-dimer levels on tacrolimus experienced the most severe outcome.
- Other patients demonstrated better outcomes, potentially linked to the immunosuppressive therapy mitigating COVID-19-induced cytokine storms.
- Elevated D-dimer levels were associated with critical illness and may serve as a prognostic indicator in KTRs with COVID-19.
Implications:
- Immunosuppressive therapy might offer a protective effect against hyperinflammation in KTRs with COVID-19.
- Monitoring D-dimer levels could be important for risk stratification and predicting outcomes in kidney transplant recipients diagnosed with COVID-19.
- Further research is warranted to elucidate the complex interplay between immunosuppression, D-dimer levels, and COVID-19 severity in KTRs.
Abstract:
Kidney transplant recipients appear to be at increased risk for severe coronavirus disease 2019 (COVID-19) illness due to some factors such as comorbidities and chronic immunosuppression. Here, we report four cases of COVID-19 infection in kidney transplant recipients. The one case in this series with the high D-dimer levels and receiving tacrolimus had the worst outcome among reported patients. Other patients had better outcomes that probably due to the effect of immunosuppressive therapy in the prevention of COVID-19-induced cytokine storm. It was suggested that a high D-dimer level occurred in critical patients and likely prognostic and also, the immunosuppressive effect of some treatment regimens.
Related Concept Videos
Kidney Transplant I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management

